Margit Stimpfl

445 total citations
16 papers, 372 citations indexed

About

Margit Stimpfl is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Margit Stimpfl has authored 16 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Hematology. Recurrent topics in Margit Stimpfl's work include Glycosylation and Glycoproteins Research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Cancer-related Molecular Pathways (3 papers). Margit Stimpfl is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Cancer-related Molecular Pathways (3 papers). Margit Stimpfl collaborates with scholars based in Austria, United States and Australia. Margit Stimpfl's co-authors include Robert Zeillinger, Sepp Leodolter, Dan Cacsire Castillo‐Tong, Andreas Obermair, Dieter Printz, P Buchinger, G. Fritsch, Helmut Gadner, Eva Schuster and Bernd Schmid and has published in prestigious journals such as Annals of the New York Academy of Sciences, Clinical Chemistry and European Journal of Cancer.

In The Last Decade

Margit Stimpfl

16 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Margit Stimpfl Austria	11	193	105	90	68	59	16	372
Kati Servan Germany	6	224 1.2×	119 1.1×	69 0.8×	105 1.5×	27 0.5×	6	389
Dmitry S. Mikhaylenko Russia	10	167 0.9×	80 0.8×	33 0.4×	86 1.3×	45 0.8×	43	369
C Mitsiades United States	7	236 1.2×	106 1.0×	97 1.1×	61 0.9×	53 0.9×	12	344
Juan Lin China	9	235 1.2×	81 0.8×	41 0.5×	111 1.6×	32 0.5×	14	365
Thomas G. Johnson Australia	6	151 0.8×	152 1.4×	121 1.3×	103 1.5×	50 0.8×	9	484
N Gutman France	14	167 0.9×	68 0.6×	128 1.4×	71 1.0×	65 1.1×	30	483
M.D. Minden Canada	7	152 0.8×	52 0.5×	86 1.0×	87 1.3×	41 0.7×	16	289
Y Miura Japan	6	168 0.9×	199 1.9×	134 1.5×	27 0.4×	140 2.4×	10	448
Bei Jin China	11	400 2.1×	122 1.2×	96 1.1×	48 0.7×	69 1.2×	15	578
Francisca Ugwu Canada	10	266 1.4×	109 1.0×	109 1.2×	208 3.1×	22 0.4×	12	454

Countries citing papers authored by Margit Stimpfl

Since Specialization

Citations

This map shows the geographic impact of Margit Stimpfl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margit Stimpfl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margit Stimpfl more than expected).

Fields of papers citing papers by Margit Stimpfl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margit Stimpfl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margit Stimpfl. The network helps show where Margit Stimpfl may publish in the future.

Co-authorship network of co-authors of Margit Stimpfl

This figure shows the co-authorship network connecting the top 25 collaborators of Margit Stimpfl. A scholar is included among the top collaborators of Margit Stimpfl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margit Stimpfl. Margit Stimpfl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Gritsch, Herbert, Margit Stimpfl, & Peter L. Turecek. (2022). Von Willebrand Factor Multimer Analysis by Low Resolution SDS-Agarose Gel Electrophoresis. BIO-PROTOCOL. 12(16). e4495–e4495. 2 indexed citations

Concin, Nicole, Dan Cacsire Castillo‐Tong, Margit Stimpfl, et al.. (2003). Comparison of p53 Mutational Status with mRNA and Protein Expression in a Panel of 24 Human Breast Carcinoma Cell Lines. Breast Cancer Research and Treatment. 79(1). 37–46. 40 indexed citations

Concin, Nicole, Margit Stimpfl, Lukas Hefler, et al.. (2003). Role of p53 in G2/M cell cycle arrest and apoptosis in response to γ-irradiation in ovarian carcinoma cell lines. International Journal of Oncology. 22(1). 51–7. 38 indexed citations

Stimpfl, Margit, Dan Cacsire Castillo‐Tong, Eva Schuster, et al.. (2002). Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.. PubMed. 8(7). 2253–9. 73 indexed citations

Schmid, Bernd, Laki Buluwela, Dan Cacsire Castillo‐Tong, et al.. (2002). Expression of MUCI Splice Variants Correlates with Invasive Growth of Breast Cancer Cell Lines. Breast Cancer Research and Treatment. 76(3). 211–219. 10 indexed citations

Obermair, Andreas, Bernd Schmid, Margit Stimpfl, et al.. (2001). Novel MUC1 Splice Variants Are Expressed in Cervical Carcinoma. Gynecologic Oncology. 83(2). 343–347. 24 indexed citations

Zeillinger, Robert, et al.. (2000). Expression of variant forms of the MUC1 gene correlates with the invasiveness of breast cancer cells. Breast Cancer Research. 2(S1). 2 indexed citations

Castillo‐Tong, Dan Cacsire, et al.. (2000). Detection of p53 Polymorphism at Codon 72 by PCR and Allele-specific Oligonucleotide Hybridization on Microtiter Plates. Clinical Chemistry. 46(1). 124–126. 8 indexed citations

Stimpfl, Margit, Bernd Schmid, Dan Cacsire Castillo‐Tong, et al.. (1999). Expression of mucins and cytokeratins in ovarian cancer cell lines. Cancer Letters. 145(1-2). 133–141. 28 indexed citations

10.

Castillo‐Tong, Dan Cacsire, Margit Stimpfl, Alexander Reinthaller, et al.. (1999). BRCA1 Gene Mutations in Sporadic Ovarian Carcinomas: Detection by PCR and Reverse Allele-specific Oligonucleotide Hybridization. Clinical Chemistry. 45(7). 976–981. 24 indexed citations

11.

Obermair, Andreas, et al.. (1999). MUC1 mucin for the detection of epithelial-derived ovarian cancer cells in peripheral blood. European Journal of Cancer. 35. S107–S107. 1 indexed citations

12.

Stimpfl, Margit, Bernd Schmid, Andreas Obermair, et al.. (1999). Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood.. PubMed. 11(8). 367–73. 6 indexed citations

13.

Fritsch, G., Dieter Printz, Margit Stimpfl, et al.. (1997). Quantification of CD34+ cells: comparison of methods. Transfusion. 37(8). 775–784. 34 indexed citations

14.

Fritsch, G., Margit Stimpfl, M. Kurz, et al.. (1996). The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.. PubMed. 17(2). 169–78. 57 indexed citations

15.

Fritsch, G., Margit Stimpfl, M. Kurz, et al.. (1995). Characterization of Hematopoietic Stem Cells. Annals of the New York Academy of Sciences. 770(1). 42–52. 11 indexed citations

16.

Fritsch, G., Margit Stimpfl, P Buchinger, et al.. (1994). Does Cord Blood Contain Enough Progenitor Cells for Transplantation?. Journal of Hematotherapy. 3(4). 291–298. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact